相关实验视频

Updated: Jan 7, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

用免疫疗法治疗B型胰岛素抵抗综合征的长期缓解:一个病例报告

Erika Egawa¹, Rei Karasawa¹, Yuka Kageyama¹

¹Division of Diabetes and Endocrinology, Japanese Red Cross Medical Center, Tokyo, Japan.

Journal of diabetes investigation

|December 26, 2025

概括

乙型胰岛素抵抗综合征是一种罕见的自身免疫性疾病,通过免疫疗法成功治疗. 这位患者在8年后在没有药物的情况下实现了长期缓解和血糖控制.

科学领域:

内分泌学在内分泌学.
免疫学免疫学免疫学
类风湿病学类风湿病学

背景情况:

B型胰岛素抵抗综合征 (BIRS) 是一种罕见的自身免疫疾病,其特征是严重的胰岛素抵抗.
患者经常出现高血糖,低血糖和细胞衰竭,这给管理带来了重大挑战.
与诸如系统性红斑狼 (SLE) 等自身免疫性疾病的同时发生是常见的.

研究的目的:

报告B型胰岛素抵抗综合征患者长期缓解的病例.
评估免疫疗法在治疗严重胰岛素抵抗和相关并发症方面的疗效.

主要方法:

一名55岁的男性患有BIRS,高血糖和细胞衰竭,接受了葡萄糖皮质类药物治疗以及mycophenolate/azathioprine的联合治疗.
通过血糖控制,血清学标志物和临床缓解来监测治疗反应.

主要成果:

患者迅速改善了血糖控制和临床缓解.
长期缓解,持续8年,是持续的.
目前,患者通过阿扎西奥普林单一治疗,非胰岛素和口服低血糖剂维持euglycemia.

结论:

免疫疗法,包括葡萄糖皮质类药物和mycophenolate/azathioprine,对于管理B型胰岛素抵抗综合征是有效的.
长期缓解和停止使用降血糖药物可以通过适当的免疫抑制治疗实现.
这一案例凸显了BIRS.在严重的代谢障碍中持续恢复的潜力.

关键词:

抗胰岛素受体抗体抗胰岛素受体抗体糖尿病糖尿病糖尿病胰岛素抵抗综合征是什么

更多相关视频

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

相关概念视频

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...